Ari Hirsch

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Losartan, the first AT1 receptor blocker (ARB), was FDA approved 15 years ago. During those years, researchers and clinicians have developed a growing base of knowledge on the benefits of losartan, particularly for hypertension and renal disease. These benefits include decreasing proteinuria, slowing the progression of diabetic nephropathy, controlling(More)
  • 1